AXS-12, known as reboxetine back when it was available as an antidepressant in the United States, may decrease cataplexy ...

Stimulants enhance ancient survival systems, helping many focus better. However, misuse and increasing demand pose risks of ...

Since 2019, these higher levels of psilocybin use reflected an increase of 188% among adults 30 and older and 44% among 18- ...

A UCSF pilot study finds psilocybin therapy surprises, showing meaningful improvements in mood, cognition, and motor symptoms.

Nerve or neuropathic pain has long been a tricky condition to treat effectively. However, a new study has comprehensively ...

More than a hundred companies are currently studying psychedelics, and experts caution against self-experimentation, as they can cause mania and psychosis. They can also impair judgment, so people can ...

While sprinkling cinnamon on food is likely safe, concentrated supplements might pose risks, especially for people taking ...

“Sources indicate that (the State Police’s) drug testing selection process is controlled by a computerized ... that he may have tested positive for antidepressants because he had been taking ...

Psilocybin, a natural compound found in certain mushrooms, has shown promise in treating depression and anxiety. UC San ...

The Cleveland Clinic is part of a multisite trial studying psilocybin to help patients with treatment-resistant depression.

“As these drugs are used more in the community, you will see more adverse events, because people are not using psilocybin in a controlled ... Rocky Mountain Poison & Drug Safety in Denver.A ...